Jupiter Wellness’ Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market

Next Frontier Pharmaceuticals’ Subsidiary Benuvia Signs Agreement with Global Wellness’ Shanti Therapeutics Benuvia has begun focusing on Psilocybin, DMT, and MDMA. Benuvia’s 83,000 square foot synthetic compound manufacturing facility is permitted by the U.S. DEA for Schedule I to III controlled substances, and is FDA registered. JUPITER, FL and ROUND ROCK, TX / January 20, […]